Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo.

Saved in:
Bibliographic Details
Title: Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo.
Authors: Xu, Xuezhen1 (AUTHOR), Kwon, Ok-Kyoung2,3 (AUTHOR), Shin, In-Sik4 (AUTHOR), Mali, Jyotirling R.1 (AUTHOR), Harmalkar, Dipesh S.1 (AUTHOR), Lim, Yourim3 (AUTHOR), Lee, Gilhye3 (AUTHOR), Lu, Qili1 (AUTHOR), Oh, Sei-Ryang3 (AUTHOR), Ahn, Kyung-Seop3 (AUTHOR), Jeong, Hye-Gwang2 (AUTHOR) hgjeong@cnu.ac.kr, Lee, Kyeong1 (AUTHOR) kaylee@dongguk.edu
Source: Scientific Reports. 1/29/2019, Vol. 9 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-018-36925-9